Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
A Chinese pharmaceutical maker is in talks with several countries to get emergency approval to use an experimental Covid-19 vaccine, developed with the Chinese military, before the completion of large-scale safety and effectiveness trials, according to a senior executive at the company.
Early distribution by CanSino Biologics Inc. would give the company a head start over rivals by making its vaccine the first to go into public use internationally outside of clinical trials, although initial dos
